It is able to successfully sense and quickly respond to the surrounding microenvironment and increase the stiffness of the extracellular matrix (ECM) and induce a mesenchymal-like phenotype in tumors, potentially making Piezo1 a viable therapeutic target for treatment-resistant and invasive gliomas. Here, PIEZO1 is linked to central nervous system cancer.